ALB

Across TCGA pan-cancer cohorts, ALB mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ALB data layer compared with 22 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher ALB mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ALB expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

PDAC, HNSC, and CCRCC are the cancer types where ALB mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	III,IV	0.520	0.958	.048	1	view →
HNSC	DFS	Median	III,IV	1.000	0.932	.038	1	view →
CCRCC	DFS	Tertile	All	0.955	0.784	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ALB–PDAC (OS)

Open the PDAC breakdown →